News for Quanterix Corporation (QTRX)

NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations

PR NewswireNEW YORK, April 22, 2025 NEW YORK, April 22, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following

PR NewswireNEW YORK, April 22, 2025 NEW YORK, April 22, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations

Kent Lake PR LLC (”œKent Lake”), a holder of approximately 7.7% of the outstanding common stock of Quanterix Corporation (”œQuanterix” or the ”œCompanyâ

Quanterix sees growth with Akoya acquisition, but rising losses and investor skepticism persist. Explore challenges and insights on QTRX's stock performance.

Mar 17, 2025 / 08:30PM GMTOperator Thank you for standing by. My name is Kathleen and I will be your conference operator today. At this time, I would like to we

Quanterix Corporation (NASDAQ:QTRX) Q4 2024 Earnings Conference Call March 17, 2025 4:30 PM ETCompany ParticipantsJoshua Young - Head of IRMasoud Toloue -...

Quanterix Corporation(NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for

The following slide deck was published by Quanterix Corporation in conjunction with their 2024 Q4 earnings call.

Revenue: $21.3 million for Q4 2024, slightly below the estimated $21.34 million, marking a 19.4% decrease from the prior year.Gross Margin: Improved to 67.4% i

MARLBOROUGH, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. ( AKYA) (”œAkoya”), The Spatial Biology Company®, today announced its finan

[url="]Quanterix Corporation[/url] (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it w

Kent Lake PR LLC (”œKent Lake”) a holder of 7.25% of the outstanding common stock of Quanterix Corporation (”œQuanterix” or the ”œCompany”) (NASDAQ: Q

ROCKVILLE, Md., March 5, 2025 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner, today announced the appointment of John Chiminski and Karen Flynn as non-executive members of its Board of Directors. John will serve as Chair of the Board and EW Healthcare Partners has designated Karen to serve on the Company's board as one of its representatives. Their leadership and deep industry expertise will be pivotal as Ascend builds its capabilities and positions itself for growth.

Quanterix Corporation (NASDAQ: QTRX) (”œQuanterix” or the ”œCompany”), a company fueling scientific discovery through ultra-sensitive biomarker detection

Kent Lake PR LLC (”œKent Lake”), a holder of 5.9% of the outstanding common stock of Quanterix Corporation (”œQuanterix” or the ”œCompany”) (NASDAQ: Q

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on

PR NewswireNEW YORK, Feb. 17, 2025 NEW YORK, Feb. 17, 2025 /PRNewswire/ --